Literature DB >> 870671

Activation of complement by hydatid cyst fluid of Echinococcus granulosus.

B Hammerberg, A J Musoke, J F Williams.   

Abstract

Factors present in hydatid cyst fluid of Echinococcus granulosus were found to interact with complement from several species. This nonimmunologic fixation resulted in the depletion of hemolytically active complement from fresh guinea pig serum, the conversion of human C3 to an electrophoretically faster species and the genration of smooth muscle contracting substances, analogous to anaphylatoxins, in normal rat serum in vitro. Vascular permeability changes were produced in vivo in rats and humans after intradermal inoculation of complement interacting fractions of hydatid fluid. It is suggested that these factors may contribute to the pathogenesis of the shock syndrome which follows intravenous administration of hydatid fluid in normal animals, and to the nonspecificity of immunodiagnostic skin tests for hydatid infection in man and animals.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870671

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  4 in total

1.  Cryoglobulins, circulating immune complexes, and complement activation in cerebral malaria.

Authors:  C Adam; M Géniteau; M Gougerot-Pocidalo; P Verroust; J Lebras; C Gibert; L Morel-Maroger
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

2.  Inhibition of antigen- and lectin-induced proliferation of rat spleen cells by a Taenia taeniaeformis proteinase inhibitor.

Authors:  R W Leid; C M Suquet; L E Perryman
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

3.  Evaluation of spleen lymphocyte responsiveness to a T-cell mitogen during early infection with larval Taenia taeniaeformis.

Authors:  T Letonja; C Hammerberg; G Schurig
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

Review 4.  Molecular and immunological diagnosis of echinococcosis.

Authors:  B Gottstein
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.